Covered recipient · General Payments record
ROBERT W DICKSON
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,996.87
- Reported across 131 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $537.40 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $230.66 | 16 |
| GlaxoSmithKline, LLC. | $79.26 | 5 |
| ABBVIE INC. | $49.79 | 3 |
| Novo Nordisk AS | $49.40 | 3 |
| PFIZER INC. | $31.27 | 2 |
| DEXCOM, INC. | $25.00 | 1 |
| Exact Sciences Corporation | $22.20 | 1 |
| Almatica Pharma Inc. | $20.39 | 1 |
| Acerta Pharma LLC | $15.52 | 1 |
| Phathom Pharmaceuticals, Inc. | $13.91 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.01 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103640478 | CMS |
| ABBVIE INC. | $14.69 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103640480 | CMS |
| ABBVIE INC. | $20.09 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103640482 | CMS |
| Almatica Pharma LLC | $20.39 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137561606 | CMS |
| Amgen Inc. | $16.20 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117541628 | CMS |
| Amgen Inc. | $16.37 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117541630 | CMS |
| Amgen Inc. | $7.46 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117541632 | CMS |
| Amgen Inc. | $10.70 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117541634 | CMS |
| Amgen Inc. | $15.92 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117541636 | CMS |
| Amgen Inc. | $8.16 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117541638 | CMS |
| Amgen Inc. | $17.26 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115575553 | CMS |
| Amgen Inc. | $15.40 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117541640 | CMS |
| Amgen Inc. | $16.61 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117541642 | CMS |
| Amgen Inc. | $14.97 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117541644 | CMS |
| Amgen Inc. | $16.90 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117541646 | CMS |
| Amgen Inc. | $16.46 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117541648 | CMS |
| Amgen Inc. | $16.60 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117541650 | CMS |
| Amgen Inc. | $17.40 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117541652 | CMS |
| Amgen Inc. | $13.64 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117541654 | CMS |
| Amgen Inc. | $10.61 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117541656 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.52 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105671723 | CMS |
| Dexcom, Inc. | $25.00 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153331331 | CMS |
| Exact Sciences Corporation | $22.20 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114636780 | CMS |
| GlaxoSmithKline, LLC. | $16.50 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116370311 | CMS |
| GlaxoSmithKline, LLC. | $17.61 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116596085 | CMS |
| GlaxoSmithKline, LLC. | $17.61 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116259517 | CMS |
| GlaxoSmithKline, LLC. | $13.77 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116640472 | CMS |
| GlaxoSmithKline, LLC. | $13.77 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116624984 | CMS |
| Novo Nordisk Inc | $16.95 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096939051 | CMS |
| Novo Nordisk Inc | $16.95 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097338447 | CMS |
| Novo Nordisk Inc | $15.50 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096780533 | CMS |
| PFIZER INC. | $15.03 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131496552 | CMS |
| PFIZER INC. | $16.24 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131632593 | CMS |
| Phathom Pharmaceuticals, Inc. | $13.91 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151055911 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.